SCHEMBL21838312

SCHEMBL21838312

CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](N)C(C)C)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.54
▸ REN P00797 7/20 0.50
▸ CYP3A4 P08684 1/20 0.49
▸ SLC7A5 Q01650 1/20 0.49
▸ ACE2 Q9BYF1 1/20 0.49
▸ ITGB2 P05107 2/20 0.48
▸ ICAM1 P05362 2/20 0.48
▸ ITGAL P20701 2/20 0.48
▸ LNPEP Q9UIQ6 3/20 0.47
▸ ERAP2 Q6P179 1/20 0.47
▸ ERAP1 Q9NZ08 1/20 0.47
▸ FNTA P49354 2/20 0.46
▸ FNTB P49356 2/20 0.46
▸ PGGT1B P53609 2/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ ANPEP P15144 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27638943 0.91 ITGB2 (0.57) SLC15A2RENCYP3A4SLC7A5ITGB2
SCHEMBL27695791 0.90 REN (0.49) SLC15A2RENCYP3A4SLC7A5ACE2
SCHEMBL29368268 0.86 SLC15A2 (0.53) SLC15A2RENCYP3A4SLC7A5ACE2
SCHEMBL27806348 0.86 CYP3A4 (0.60) SLC15A2CYP3A4SLC7A5ITGB2ICAM1
SCHEMBL29728766 0.86 CYP3A4 (0.60) SLC15A2CYP3A4SLC7A5ITGB2ICAM1
SCHEMBL29349749 0.85 CYP3A4 (0.53) SLC15A2RENCYP3A4SLC7A5ACE2
SCHEMBL28410134 0.85 SLC15A2 (0.58) SLC15A2RENACE2ITGB2ICAM1
SCHEMBL28457067 0.85 SLC15A2 (0.76) SLC15A2RENCYP3A4SLC7A5ITGB2
SCHEMBL30595016 0.84 CYP3A4 (0.57) SLC15A2RENCYP3A4SLC7A5ACE2
SCHEMBL21828702 0.84 CYP3A4 (0.57) SLC15A2RENCYP3A4SLC7A5ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200200769-A1 METHOD FOR MEASURING GLYCATED HEMOGLOBIN HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD. (JP) 2020-06-25 — — US disclosed
EP-3636767-A1 METHOD FOR MEASURING GLYCATED HEMOGLOBIN Hitachi Chemical Diagnostics Systems Co., Ltd. (JP) 2020-04-15 — — EP disclosed
CN-101948906-B Reagent with protease reaction promoter and/or pigment stabilizing agent ASAHI KASEI PHARMA CORP 2013-02-27 — — CN disclosed
CN-101948906-A The reagent that contains protease reaction promoter and/or colorant stabilizer ASAHI KASEI PHARMA CORP 2011-01-19 — — CN disclosed
CN-101023168-B Reagent containing protease reaction promoter and/or pigment stabilizer ASAHI KASEI PHARMA CORP 2010-10-13 — — CN disclosed
CN-100379875-C Method for producing alpha-glycated dipeptide and method for measuring amount of alpha-glycated dipeptide KIKKOMAN CORP (JP) 2008-04-09 — — CN disclosed
CN-101023168-A Reagent containing protease reaction promoter and/or pigment stabilizer ASAHI KASEI PHARMA CORP (JP) 2007-08-22 — — CN disclosed
CN-1852987-A Method for producing alpha-glycated dipeptide and method for measuring amount of alpha-glycated dipeptide KIKKOMAN CORP (JP) 2006-10-25 — — CN disclosed
Send feedback